These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 28692818)
41. [Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. Yafour N; Bekadja MA; Chevallier P; Cabrera Q; Coman T; Elkababri M; Hamzy F; Quessar A; Laamiri A; Pochon C; Yakoub-Agha I; Harif M Bull Cancer; 2021 Dec; 108(12S):S10-S19. PubMed ID: 34247762 [TBL] [Abstract][Full Text] [Related]
42. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Passweg JR; Baldomero H; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Kuball J; Lankester A; Montoto S; de Latour RP; Snowden JA; Styczynski J; Yakoub-Agha I; Arat M; Mohty M; Kröger N; Bone Marrow Transplant; 2019 Oct; 54(10):1575-1585. PubMed ID: 30728439 [TBL] [Abstract][Full Text] [Related]
43. Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders. Bhatt ST; Bednarski JJ Front Immunol; 2020; 11():1988. PubMed ID: 33013851 [TBL] [Abstract][Full Text] [Related]
44. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Fenske TS; Zhang MJ; Carreras J; Ayala E; Burns LJ; Cashen A; Costa LJ; Freytes CO; Gale RP; Hamadani M; Holmberg LA; Inwards DJ; Lazarus HM; Maziarz RT; Munker R; Perales MA; Rizzieri DA; Schouten HC; Smith SM; Waller EK; Wirk BM; Laport GG; Maloney DG; Montoto S; Hari PN J Clin Oncol; 2014 Feb; 32(4):273-81. PubMed ID: 24344210 [TBL] [Abstract][Full Text] [Related]
45. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia. Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263 [TBL] [Abstract][Full Text] [Related]
46. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations. Marotta S; Pagliuca S; Risitano AM Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515 [TBL] [Abstract][Full Text] [Related]
47. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances. Epperla N; Hamadani M Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038 [TBL] [Abstract][Full Text] [Related]
48. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206 [TBL] [Abstract][Full Text] [Related]
49. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation. Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669 [TBL] [Abstract][Full Text] [Related]
50. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 1. Aplastic anemia]. Teramura M Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1928-36. PubMed ID: 22896996 [No Abstract] [Full Text] [Related]
51. Inherited bone marrow failure syndromes in 2012. Sakaguchi H; Nakanishi K; Kojima S Int J Hematol; 2013 Jan; 97(1):20-9. PubMed ID: 23271412 [TBL] [Abstract][Full Text] [Related]
52. Unmanipulated haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in a patient with paroxysmal nocturnal hemoglobinuria and secondary aplastic anemia. Sarmiento M; Ramírez PA Bone Marrow Transplant; 2016 Feb; 51(2):316-8. PubMed ID: 26501768 [No Abstract] [Full Text] [Related]
53. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Kharfan-Dabaja MA; Kumar A; Ayala E; Hamadani M; Reimer P; Gisselbrecht C; d'Amore F; Jantunen E; Ishida T; Bazarbachi A; Foss F; Advani R; Fenske TS; Lazarus HM; Friedberg JW; Aljurf M; Sokol L; Tobinai K; Tse E; Burns LJ; Chavez JC; Reddy NM; Suzuki R; Ahmed S; Nademanee A; Mohty M; Gopal AK; Fanale MA; Pro B; Moskowitz AJ; Sureda A; Perales MA; Carpenter PA; Savani BN Biol Blood Marrow Transplant; 2017 Nov; 23(11):1826-1838. PubMed ID: 28797780 [TBL] [Abstract][Full Text] [Related]
54. Acquired and Inherited Bone Marrow Failure Syndromes. Sieff CA Hematol Oncol Clin North Am; 2018 Aug; 32(4):xiii-xiv. PubMed ID: 30047424 [No Abstract] [Full Text] [Related]
55. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Hegenbart U; Niederwieser D; Forman S; Holler E; Leiblein S; Johnston L; Pönisch W; Epner E; Witherspoon R; Blume K; Storb R Biol Blood Marrow Transplant; 2003 Nov; 9(11):689-97. PubMed ID: 14652852 [TBL] [Abstract][Full Text] [Related]
56. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial. Giralt S; Costa LJ; Maloney D; Krishnan A; Fei M; Antin JH; Brunstein C; Geller N; Goodman S; Hari P; Logan B; Lowsky R; Qazilbash MH; Sahebi F; Somlo G; Rowley S; Vogl DT; Vesole DH; Pasquini M; Stadtmauer E Biol Blood Marrow Transplant; 2020 Apr; 26(4):798-804. PubMed ID: 31756536 [TBL] [Abstract][Full Text] [Related]
57. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016. Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715 [TBL] [Abstract][Full Text] [Related]
58. Outcome following second allogeneic hematopoietic cell transplantation: A single-center experience. Aljasem HA; Messner HA; Lipton JH; Kim DDH; Viswabandya A; Thyagu S; Deotare U; Michelis FV Eur J Haematol; 2018 Mar; 100(3):308-314. PubMed ID: 29240253 [TBL] [Abstract][Full Text] [Related]
59. Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Dufour C; Pillon M; Passweg J; Socié G; Bacigalupo A; Franceschetto G; Carraro E; Oneto R; Risitano AM; Peffault de Latour R; Tichelli A; Rovo A; Peters C; Hoechsmann B; Samarasinghe S; Kulasekararaj AG; Schrezenmeier H; Aljurf M; Marsh J Haematologica; 2014 Oct; 99(10):1574-81. PubMed ID: 25085353 [TBL] [Abstract][Full Text] [Related]
60. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014. Visconte V; Lindsley RC; Berlyne D Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]